Sector:
MedTech
About
Quibim is a healthtech company pioneering tools that unlock imaging data to improve patient outcomes. Quibim is at the forefront of imaging biomarkers research in life sciences, driving the development of advanced algorithms that transform imaging data into actionable predictions in oncology, immunology, and neurology. The company leverages the capabilities of MRI, CT, and PET imaging to create regulatory-cleared Medical Devices that are seamlessly integrated into the workflows of healthcare providers worldwide. More than 170 healthcare institutions, research centers, hospitals, and clinical facilities are using Quibim products globally. In addition, Quibim has partnerships with Merck KGaA to develop imaging biomarker models to predict responses of cancer patients to immunotherapy and inform decisions in its global drug development efforts and with Phillips to launch AI-based imaging and reporting solutions for MRI prostate exams. Quibim has offices in New York City, US, Cambridge, UK, Valencia, Madrid, and Barcelona, Spain.
YouTube
Team
